Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Vaccines. 2016;15(4):467-82. doi: 10.1586/14760584.2016.1121814. Epub 2015 Dec 15.

Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.

Author information

  • 1a Department of Infectious Diseases, Molecular Virology , Heidelberg University , Heidelberg , Germany.
  • 2b German Center for Infection Research , Heidelberg University , Heidelberg , Germany.

Abstract

Highly effective prophylactic vaccines for flaviviruses including yellow fever virus, tick-borne encephalitis virus and Japanese encephalitis virus are currently in use. However, the development of a dengue virus (DENV) vaccine has been hampered by the requirement of simultaneous protection against four distinct serotypes and the threat that DENV-specific antibodies might either mediate neutralization or, on the contrary, exacerbate disease through the phenomenon of antibody-dependent enhancement (ADE) of infection. Therefore, understanding the cellular, biochemical and molecular basis of antibody-mediated neutralization and ADE are fundamental for the development of a safe DENV vaccine. Here we summarize current structural and mechanistic knowledge underlying these phenomena. We also review recent results demonstrating that the humoral immune response triggered during natural DENV infection is able to generate neutralizing antibodies binding complex quaternary epitopes only present on the surface of intact virions.

KEYWORDS:

ADE; Dengue virus; antibody-dependent enhancement of infection; antigenic structure; human humoral response; immature viral particles; neutralization; quaternary epitopes; tetravalent vaccine; virus dynamics; virus entry

PMID:
26577689
DOI:
10.1586/14760584.2016.1121814
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center